Compound: Cabozantinib

Drug Target: VEGFR, MET, RET, KIT, FLT1, FLT3, FLT4, TIE2,AXL

Drug Target pathway: RTK signaling

Dataset


Associations from all tissue specific and pan-cancer ANOVA analyses overlaid. Hover the pointer over each circle to reveal the context-specific details of an association.

Retrieving drug sensitivity data...

Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.